View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Vasculitis and Giant Cell Arteritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 11, 2019
2 min read
Save

Repeat rituximab superior to azathioprine for preventing relapse in ANCA-associated vasculitis

Repeat rituximab superior to azathioprine for preventing relapse in ANCA-associated vasculitis

ATLANTA — Treatment with repeat doses of rituximab is superior to daily azathioprine for preventing relapse among patients with ANCA-associated vasculitis with a history of relapse, according to data presented at the 2019 ACR/ARP Annual Meeting.

SPONSORED CONTENT
October 29, 2019
2 min read
Save

Cancer, infection risk higher among patients treated with IL inhibitors

Cancer, infection risk higher among patients treated with IL inhibitors

Rheumatology patients treated with interleukin inhibitors have an increased risk for serious infections, opportunistic infections and cancer, according to data published in JAMA Open Network.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
October 21, 2019
2 min read
Save

Cyclophosphamide 'not dead yet' for ANCA-associated vasculitis

Cyclophosphamide 'not dead yet' for ANCA-associated vasculitis

SAN DIEGO — Although fading from use in vasculitis management strategies, cyclophosphamide still offers several benefits for a minority of patients who are unable to switch to other therapies, according to a presenter at the 2019 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
October 16, 2019
2 min read
Save

Deciphering telltale symptoms of vasculitis, Erdheim-Chester disease

Deciphering telltale symptoms of vasculitis, Erdheim-Chester disease

SAN DIEGO — Rheumatologists should exercise caution when diagnosing patients with suspected vasculitis as several lesser-known diseases can affect the large and medium-sized arteries imitating vasculitis, according to a presenter at the 2019 Congress of Clinical Rheumatology West.

SPONSORED CONTENT
September 27, 2019
1 min read
Save

FDA expands Rituxan indication for children with vasculitis diseases

FDA expands Rituxan indication for children with vasculitis diseases

The FDA announced the approval of Rituxan injection to treat granulomatosis with polyangiitis and microscopic polyangiitis in children 2 years and older in combination with glucocorticosteroids.

SPONSORED CONTENT
September 20, 2019
13 min read
Save

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

When Autoimmune Disease Strikes Thrice: Managing Multiple Autoimmune Syndrome

By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already been living with an autoimmune disease for 12 years.

SPONSORED CONTENT
September 16, 2019
2 min read
Save

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases, including acute anterior uveitis, psoriasis, thromboangiitis obliterans, Behcet’s disease and sarcoidosis, according to findings published in Arthritis Research & Therapy.

SPONSORED CONTENT
August 20, 2019
2 min read
Save

Giant cell arteritis incidence similar among black, white patients

Giant cell arteritis incidence similar among black, white patients

Contrary to widespread belief that biopsy-proven giant cell arteritis is comparatively rare among black patients, researchers found the condition occurs at a similar rate among black and white patients, according to data published in JAMA Ophthalmology.

SPONSORED CONTENT
August 19, 2019
16 min read
Save

Lumpers, Splitters, and the Move Toward New Taxonomy for Rheumatology

Lumpers, Splitters, and the Move Toward New Taxonomy for Rheumatology

Historians attribute Philip II of Macedon — father of Alexander the Great — as the source of the motto and political principle known as “divide and conquer.” As a ruling technique, the maxim worked, with Phillip ultimately ruling over most of classical Greece; a success that would be repeated with Julius Caesar and Napoleon Bonaparte in the centuries to follow.

SPONSORED CONTENT
August 19, 2019
2 min read
Save

Older maternal age linked to adverse outcomes in Kawasaki disease

Older maternal age linked to adverse outcomes in Kawasaki disease

A maternal age of 32 years or older is significantly associated with adverse pregnancy outcomes, including the formation of coronary artery lesions, and in cases of a maternal age of 35 years of older, IV immunoglobulin resistance, among offspring with Kawasaki disease, according to data published in Pediatric Rheumatology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails